Post-surgical wound infections involving Enterobacteriaceae with reduced susceptibility to β-lactams in two Portuguese hospitals

International Wound Journal

Volumn 7, Issue 6, 2010, Pages 508-514

  Fernandes, Rúben ^a,b   Prudêncio, Cristina ^a,b  

^a POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

Enterobacteriaceae; Extended spectrum lactamases; Nosocomial infections; Post surgical infections; Skin and soft tissue infections

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HOSPITAL; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIXED INFECTION; PORTUGAL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SKIN INFECTION; SOFT TISSUE INFECTION; SURGICAL INFECTION;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; COMMUNICABLE DISEASES, EMERGING; CROSS INFECTION; DNA FINGERPRINTING; DNA, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INFECTION CONTROL; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PILOT PROJECTS; POPULATION SURVEILLANCE; PORTUGAL; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 78649646012     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2010.00723.x     Document Type: Article

References (35)

1. Wilson MA., Skin and soft-tissue infections: impact of resistant gram-positive bacteria. Am J Surg 2003; 186 (Suppl): 35 - 41.
2. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG., CDC definitions of nosocomial surgical site infections. Infect Control Hosp Epidemiol 1992; 13: 606 - 8.
3. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR., Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 2006; 57: 7 - 13.
4. Martone WJ, Nichols RL., Recognition, prevention, surveillance, and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis 2001; 33 Suppl 2: 67 - 8.
5. Department of Food Safety, Zoonoses and Foodborne Diseases. Critically Important Antimicrobials for Human Medicine: Categorization for the development of risk management strategies to contain antimicrobial resistance due to non-human antimicrobial use. In: Report of the 2nd WHO Expert Meeting Copenhagen, World Health Organization, 2007.
6. Bloomfield SF, Cookson B, Falkiner F, Griffith C, Cleary V., Methicillin-resistant Staphylococcus aureus, Clostridium difficile, and extended-spectrum β-lactamase-producing Escherichia coli in the community: assessing the problem and controlling the spread. Am J Infect Control 2007; 35: 86 - 8.
7. Shukla SK., Community-associated methicillin-resistant Staphylococcus aureus and its emerging virulence. Clin Med Res 2005; 3: 57 - 60.
8. Versalovic J, Koeuth T, Lupski JR., Distribution of repetitive DNA sequences in Eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 1991; 19: 6823 - 31.
9. CLSI (Clinical and Laboratory Standards Institute). Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, 6th edn. Wayne, PA: Clinical and Laboratory Standards Institute, 2003: M7 - A6.
10. CLSI. Performance standard for antimicrobial susceptibility testing. Wayne, PA: Clinical and Laboratory Standards Institute, 2005: M100 - S15.
11. Álvarez M, Tran JH, Chow N, Jacoby GA., Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob Agents Chemother 2004; 48: 533 - 7.
12. Bonfiglio G, Laksai Y, Franchino L, Amicosante G, Nicoletti G., Mechanisms of β-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey. J Antimicrob Chemother 1998; 42: 697 - 702.
13. Mabilat C, Goussard S., PCR detection and identification of gene for extended-spectrum β-lactamases. In:, Persing DH, Smith TF, Tenover FC, White TC, editors. Diagnostic molecular microbiology: principles and applications. Washington: American Society for Microbiology Press, 1993: 553 - 9.
14. Nüesch-Inderbinen MT, Hächler H, Kayser FH., Detection of genes coding for extended-spectrum SHV β-lactamases in clinical isolates by molecular genetics method and comparison with E-test. Eur J Clin Microbiol Infect Dis 1996; 15: 398 - 402.
15. Batchelor M, Hopkins K, Threlfall EJ, Clifton-Hadley FA, Stallwood AD, Davies RH, Liebana E., bla(CTX-M) genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob Agents Chemother 2005; 49: 1319 - 22.
16. Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ, Williams PP, Brittain KL, Oliver A, McGowan JE Jr, Tenover FC., Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum β-lactamase detection methods. J Clin Microbiol 2001; 39: 2864 - 72.
17. Sabaté M, Tarragó R, Navarro F, Miró E, Vergés C, Barbé J, Prats G., Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-9) from Escherichia coli in Spain. Antimicrob Agents Chemother 2000; 44: 1970 - 73.
18. Woodford N, Fagan EJ, Ellington MJ., Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob Chemother 2006; 57: 154 - 5.
19. Naiemi NA, Duim B, Savelkoul PMH, Spanjaard L, Jonge E, Bart A, Vandenbroucke-Grauls CM, Jong MD., Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol 2005; 43: 4862 - 4.
20. Chaudhary SB, Vives MJ, Basra SK, Reiter MF., Postoperative spinal wound infections and postprocedural diskitis. J Spinal Cord Med 2007; 30: 441 - 51.
21. Giacometti A, Cirioni O, Schimizzi AM, Del Prete MS, Barchiesi F, D'Errico MM, Petrelli E, Scalise G., Epidemiology and microbiology of surgical wound infections. J Clin Microbiol 2000; 38: 918 - 22.
22. Costa D, Poeta P, Sáenz Y, Coelho AC, Matos M, Vinué L, Rodrigues J, Torres C., Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets. Vet Microbiol 2008; 127: 97 - 105.
23. Fernandes R, Gestoso A, Freitas JM, Santos P, Prudêncio C., Emergence of high resistance to fourth generation cephalosporins among clinical isolates of Enterobacteriaceae producing extended-spectrum β-lactamases isolated in the north of Portugal. Int J Antimicrob Agents 2008; 70: 93 - 5.
24. Mendonça N, Leitão J, Manageiro V, Ferreira E, Caniça M., Spread of extended-spectrum β-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob Agents Chemother 2007; 51: 1946 - 55.
25. Machado E, Coque TM, Cantón R, Baquero F, Sousa JC, Peixe L, Portuguese Resistance Study Group. Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6′)-Ib-cr gene, which encodes an aminoglycoside- and fluoroquinolone-modifying enzyme. Antimicrob Agents Chemother 2006; 50: 3220 - 1.
26. Hernández JR, Martínez-Martínez L, Cantón R, Coque TM, Pascual A., Nationwide study of Escherichia coli and K. pneumoniae producing extended-spectrum β-lactamases in Spain. Antimicrob Agents Chemother 2005; 49: 2122 - 5.
27. Miro E, Mirelis B, Navarro F, Rivera A, Mesa RJ, Roig, MC, Gomez L, Coll P., Surveillance of extended-spectrum β-lactamases from clinical samples and faecal carriers in Barcelona, Spain. J Antimicrob Chemother 2005; 56: 1152 - 5.
28. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, Ayala J, Coque TM, Kern-Zdanowicz I, Luzzaro F, Poirel L, Woodford N., CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007; 59: 165 - 174.
29. Bonnet R., Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1 - 14.
30. Aiello AE, Marshall B, Levy SB, Della-Latta P, Lin SX, Larson E., Antibacterial cleaning products and drug resistance. Emerg Infect Dis 2005; 11: 1565 - 70.
31. Grigoryan L, Burgerhof JG, Degener JE, Deschepper R, Lundborg CS, Monnet DL, Scicluna EA, Birkin J, Haaijer-Ruskamp FM, SAR consortium. Attitudes, beliefs and knowledge concerning antibiotic use and self-medication: a comparative European study. Pharmacoepidemiol Drug Saf 2007; 16: 1234 - 43.
32. Siegel JD, Rhinehart E, Jackson M, Chiarello L,; Healthcare Infection Control Practices Advisory Committee. Management of Multidrug-Resistant Organisms in Healthcare Settings. Am J Infect Control 2007; 35 (Suppl 2): 165 - 93.
33. Larson EL, Quiros D, Giblin T, Lin S., Relationship of antimicrobial control policies and hospital characteristics to antimicrobial resistance rates. Am J Crit Care 2007; 16: 110 - 9.
34. MacAdam H, Zaoutis TE, Gasink LB, Bilker WB, Lautenbach E., Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use. Int J Antimicrob Agents 2006; 28: 325 - 32.
35. Mroczkowski P, Lauf H, Lippert H, König W, Meyer F., Microbial spectrum in surgical infections based on a microbiological routine monitoring over the 10-year period from 1995 to 2004. Zentralbl Chir 2009; 134: 226 - 30. Article in German.